2877 — China Shineway Pharmaceutical Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual balance sheet for China Shineway Pharmaceutical, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	3,943	4,206	5,046	5,909	6,490
Net Total Accounts Receivable
Net Total Receivables	761	825	975	1,260	1,202
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	5,519	5,699	6,782	8,155	8,599
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1,395	1,252	1,217	1,205	1,219
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	7,214	7,204	8,232	9,574	10,042
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	1,195	1,098	1,666	2,434	2,450
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	1,419	1,302	1,849	2,539	2,575
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Total Equity	5,794	5,901	6,383	7,035	7,467
Total Liabilities & Shareholders' Equity	7,214	7,204	8,232	9,574	10,042
Total Common Shares Outstanding